Inquiry Basket
Oligonucleotides are the chemical backbone of PCR technologies and molecular diagnostics. They are used to prime DNA synthesis, hybridize to targets of interest and act as internal controls in these assays. PCR-based detection and identification of infectious agents, mutations and gene expression are common applications of oligonucleotides in diagnostics. Mutations can be detected using allele specific oligonucleotides (ASO) and a polymerase reaction. Many tools are available to increase the sensitivity and specificity of diagnostic PCR reactions. Oligonucleotides designed for use in diagnostics can help confirm the presence of infectious agents, disease-causing mutations as well as help identify oncogenes. The chemical modifications made to these oligonucleotides affect their sensitivity, specificity and ability to be reproduced in diagnostics.
Schematic diagram of ORNi-PCR and its application to the detection of nucleotide differences1,5
Oligonucleotides are commonly used as reagents for amplification-based detection platforms. Amplification assays require oligonucleotides as primers to establish the starting and ending point of amplification and as oligonucleotide probes to detect accumulation of the product during the reaction. Primers can potentially bind to unintended targets leading to false positives or they may fail to anneal to the target sequence resulting in false negatives. Design of these primers is critical to the specificity of the assay. Synthetic oligonucleotide probes labeled with fluorescent reporters on each end are used in quantitative PCR as the means of signal detection, which is proportional to the amount of amplicon present during the reaction. Detection of inhibition or lack of amplification can also be accomplished using control oligonucleotides. Fluorescent or affinity-tagged oligonucleotides can also be used for applications beyond detection during amplification such as multiplex detection, fluorescence in situ hybridization assays, or next-generation sequencing library preparation.
| Oligonucleotide Type | Primary Function | Critical Design Consideration |
| Forward/Reverse Primers | Initiate polymerization at target boundaries | Specificity and thermal stability optimization |
| Hydrolysis Probes | Real-time detection via reporter release | Quencher-fluorophore spectral compatibility |
| Molecular Beacons | Conformation-dependent signal generation | Stem-loop stability versus target accessibility |
| Internal Controls | Assay validation and inhibition monitoring | Sequence distinctiveness from analytical target |
Table 1 Functional Categories of Diagnostic Oligonucleotides
Primers are forward and reverse oligonucleotides that bind to the ends of the sequence of interest. These sequences serve as the starting point for DNA synthesis since they supply the free 3'-OH group that DNA polymerase extends from. An important aspect of primer design is that they should have a high percentage of bases that are complementary to the target sequence and be able to hybridize at a high temperature. Additionally, primers should be devoid of regions that are complementary to each other to prevent formation of primer-dimers. Probes can be thought of as pieces of DNA that allow for detection of a specific sequence. Hydrolysis probes become fluorescent when the sequence they are bound to is amplified, whereas hybridization probes bind to the sequence of interest and change fluorescence through energy transfer. Controls are DNA sequences that are added to the reaction mix to check for inhibition. Additionally, internal positive controls are usually added to a reaction to ensure that all components are working properly. Controls help assure that a negative result is truly negative.
Targets for oligonucleotide diagnostics are often synthetic and include nucleotide analogs. Many molecular diagnostic oligonucleotides are modified with a fluorescent dye at either or both ends, which allows visualization with different optics after hybridization to a target nucleic acid. Dark quenchers are also often attached near fluorescent labels that will quench the fluorescence of the dye until the oligonucleotide is hybridized to its target or digested by a nucleic acid cleaving enzyme. Backbone modifications like locked nucleic acids (LNA) or peptide nucleic acids (PNA) have increased affinity to their complement and greater specificity to mismatches. Other modifications like minor groove binders or non-nucleosidic linkers can affect Tm and flexibility of the oligonucleotide.
Primer design is often one of the most important aspects of successful amplification using the PCR. Primers can be optimized to anneal specifically to a target sequence by modifying features such as melting temperature, sequence length, GC-content, self-complementarity, and target specificity. Primer design is especially important when designing primers for quantitative PCR or diagnostic PCR. The reaction efficiency of PCR depends on primer design, therefore consistent signal generation is dependent on primer design when designing quantitative PCR assays. Since diagnostic PCRs are often used to make clinical decisions, primer specificity is essential to obtaining accurate results. Newer PCR chemistries and detection instruments have complicated primer design by introducing new factors that must be taken into consideration when designing primers such as hairpin structures and interaction with fluorophores.
The ligation-based genetic variant typing assay is composed of three sequentially conducted enzymatic assays2,5
Primer length, GC percentage, and melting temperature are properties that must all be considered together. A primer should ideally be between 18 and 30 bases long. If it is shorter than 18 bases it may not uniquely bind to the target sequence. If it is longer than 30 bases it may form secondary structures or bind slowly. Ideally a primer's GC percentage is between 40% and 60%. Lower percentages may cause the primer not to anneal properly to the template. Higher percentages may cause the primer to form secondary structures or be difficult to synthesize. Optimal annealing temperature is based on melting temperature as predicted by nearest-neighbor calculations. Typically, this should be between 55°C and 65°C. The melting temperatures of each primer in a pair should not differ by more than 2 °C so that both primers will efficiently bind at the same temperature. If one primer binds much more slowly than the other, less double-stranded DNA product will be produced, decreasing the yield and efficiency of the reaction.
A common cause of amplification inefficiency and non-specific amplification products is primer dimerization and secondary structure formation. Primer dimers occur when the forward and reverse primer anneal to each other or when a primer can bind to itself, forming a secondary structure. Secondary structures such as hairpins occur when the primer anneals to itself internally. Hairpins will interfere with amplification by physically inhibiting the access of DNA polymerase to the 3'OH group of the primer by steric effects. By computing the free energy of potential secondary structures, including primer-dimers and hairpins, many of these can be screened out. Generally a free energy score of less than −3 kcal/mol for hairpins and less than −5 kcal/mol for primer dimers is considered acceptable. The most detrimental structures will have complementarity at the 3'end. As little as one stable base pair here can inhibit extension by polymerase completely or contribute to non-specific amplification by becoming the predominant reaction (eutopic amplification).
Probe design is another important aspect of qPCR assay design that impacts specificity and sensitivity. The nucleotide sequence and various modifications to probe chemistry need to be considered during probe design. Probes can be labeled on both ends with a fluorophore and a quencher dye (reporter dye). Other types of probes include molecular beacons and traditional quenchers. Regardless of probe type, melting temperatures should be optimized to be higher than the primers used for amplification and low enough to allow efficient binding of the probe before primer extension. Mismatch discrimination should be preserved with these optimized melting temperatures. Additionally, fluorophores and quenchers should be selected based on detection capabilities. Dark quenchers are more effective than fluorescent quenchers at reducing background signal.
Linear (hydrolysis) probes or dual-labelled probes are the most commonly used detection chemistry for qPCR. They are oligonucleotides with a reporter dye attached to the 5' end and a quencher attached to the 3' end. As such when the probe is intact, fluorescence is quenched by FRET between the reporter dye and the quencher. When the probe hybridises during PCR amplification to its target sequence it becomes vulnerable to cleavage by the 5' exonuclease activity of the DNA polymerase. This process detaches the probe from the amplicon, thereby releasing the reporter dye from the quencher and producing detectable fluorescence. Linear probes are typically 20–30 nt in length and have melting temperatures several degrees higher than the PCR primers.
Hybridization probes come in many configurations that allow detection without enzymatic cleavage of the probe. Molecular beacons are constructed in a stem-loop configuration with a fluorophore and quencher on each end of the nucleic acid strand. When hybridized with target, the stem is displaced exposing the fluorophore and quencher from each other, once again producing fluorescence. Molecular beacons have the advantage that they are sequence-specific. If incorrect bases are present in the target strand, the beacon will not hybridize properly and fluorescence will not occur. Other configurations include displacement probes or even simple duplexes that change conformation upon target hybridization.
Synthetic oligonucleotide quality is a major factor in the success of diagnostic assays. Impurities in synthetic oligonucleotides including degraded fragments, incomplete desalted material, and synthesis byproducts can lead to false negative results if the oligonucleotide fails to amplify correctly or false positive results if there is non-specific amplification. For clinical and scientific applications relying on quantitation of nucleic acids, inconsistent oligonucleotide quality can lead to variability that may affect patient care. As molecular diagnostics transition from the research laboratory to the regulated clinical laboratory setting, there are increasing requirements for the quality of nucleic acids, which include chemical quality, sequence accuracy, and consistency. Quality requirements are especially important for nucleic acids used in quantitative applications where the number of copies must be accurately determined and in diagnostic applications such as pathogen detection or clinical genotyping where incorrect results could have serious implications. Quality control surrounding the synthesis, purification, and verification of oligonucleotides is necessary to ensure that the oligonucleotides will perform consistently during their entire lifespan.
| Quality Attribute | Assessment Method | Performance Impact |
| Chemical purity | Chromatographic analysis | Consistent amplification efficiency |
| Sequence fidelity | Mass spectrometric verification | Accurate target recognition |
| Batch consistency | In-process testing and documentation | Reproducible assay performance |
| Stability | Accelerated degradation studies | Reliable shelf life and storage |
Table 2 Quality Parameters for Diagnostic Oligonucleotides
Diagnostic efficacy depends on oligonucleotide purity. Common contaminants include deletion sequences, truncated coupling products, and residual protecting groups. These contaminants will compete with full-length species for target hybridization and enzymatic recognition. Full-length species is usually determined with high-performance liquid chromatography or capillary electrophoresis. Requirements for purity usually exceed 85% for diagnostic and therapeutic uses. Batch-to-batch consistency means that oligonucleotides synthesized on different days or at different scales have the same performance characteristics. This is usually accomplished by carefully defined manufacturing methods, stringent in-process controls, and complete record keeping of all reaction conditions during oligonucleotide synthesis. Variation in coupling efficiency, deprotection conditions, or purification recovery can change the actual amount of oligonucleotide in each production batch. Changes in synthesis efficiency will cause problems with comparing assays over time and between laboratories.
Diagnostic sensitivity and specificity can be impacted by the quality of the oligonucleotides used. Degraded oligonucleotides or impurities such as shorter primer fragments result in less efficient amplification reactions. For degraded primers, this increase in the cycle threshold can make samples that would otherwise test as low-positive test as negatives. This can be especially problematic in samples from early infections where the amount of target in the sample may be near the limits of detection. Impurities can also increase background signals non-specifically such as primer-dimerization or probe-target binding events that would lead to false positive results and potentially overtreatment. Modification chemistry can also effect sensitivity if the detection moieties (fluorescent dyes/quenchers) are degraded or not fully conjugated to the oligonucleotide backbone. Decreased modification moieties will decrease the dynamic range of the detection reaction. Sequence mismatches caused by synthesis errors can effect specificity if the oligonucleotide binds to a sequence with single nucleotide polymorphisms or induces off-target amplification through frameshifts.
Oligonucleotides are chemical building blocks commonly used as reagents in amplification-based detection platforms. Amplification reactions can fail or produce unreliable results for a number of reasons, however, often due to flaws with the oligonucleotides themselves. Common issues include generation of nonspecific byproducts (primer-dimers, off-target amplicons) or poor signal (low fluorescence, high background). These issues can be caused by poor oligonucleotide design, impurities introduced during synthesis or storage, product degradation, or reaction conditions that push the limits of the chemical stability of the oligonucleotides. By knowing the possible failure modes, one can troubleshoot and correct issues by redesigning primers, increasing quality controls, etc.
General amplification refers to amplification of products other than the desired target. Two types of general amplification are primer dimers and nonspecific products. Primer dimers are caused by self-complementary primer sets annealing to each other. Primer dimers usually appear as smears lower than 100bp on a gel image. Non-specific products have partial homology to sequences within the reaction mixture. Multiple bands on a gel or multiple peaks on a melt curve are the result of nonspecific amplification. General amplification products waste reagents that could be used to amplify the intended target. They can also cause false positives if quantification or detection is based on specificity to the target of interest. Ways to avoid general amplification are using software to prevent self-complementarity of primers, using hot-start polymerases, adjusting annealing temperatures, and decreasing primer concentrations.
In general terms quantitatively bad signals are those that are too dim to see or have high background that interferes with seeing specific signal. Causes of dim signals can include instability of the probe itself, poor hydrolysis of a hydrolysis probe due to low enzyme activity, or poor overlap between the emission spectrum of the fluorophore and the excitation spectrum of the quencher. Causes of high background can include incomplete quenching of the fluorophore when the probe is intact, probe aggregation, or nonspecific binding of the probe to other reaction ingredients causing fluorescence in the absence of target amplified product. All of these problems are exacerbated when trying to detect low copy numbers of a target. Ways to troubleshoot this problem include checking the quality of your probe (ion exchange HPLC can be used here) ensure you are using an optimal concentration of probe and use a fluorophore/quencher pair that have high spectral overlap.
Modified oligonucleotides are commonly used for diagnostic assays. Modifications to oligonucleotides can aid assay sensitivity, specificity, and stability compared to unmodified oligonucleotides. Modifications used in diagnostics include labels (fluorescent dyes), quencher groups, and stabilizing modifications. Modified oligonucleotides are used in many diagnostic platforms including infectious disease assays, genetic testing, and cancer monitoring. Design of diagnostic assays heavily relies on the sensitivity and specificity of the assay. Selective chemical modifications can help improve the sensitivity of an assay by generating a stronger signal or improving mismatch discrimination. Stability of the oligonucleotide can also be improved to function in many different sample types and storage conditions. Chemical modifications can help with accurate patient stratification.
Detection chemistries are divided into two categories fluorescent labels and quenchers. Fluorescent labels used in real-time quantitative PCR include molecules such as fluorescein, cyanine dyes and rhodamine derivatives. These dyes are conjugated to oligonucleotide probes such that when they are bound to a target, the label produces a fluorescent signal. Dark quenchers include many dye derivatives which absorb light but do not fluoresce. Quenchers are conjugated to oligonucleotide probes as well. A quencher placed adjacent to a fluorophore absorbs the emitted fluorescence through Förster resonance energy transfer, preventing signal from being produced. When the oligonucleotide hybridizes to its target (or is enzymatically digested away from the quencher), the fluorophore and quencher are separated and signal is produced. Fluorescent labels are vital for real-time qPCR because they allow absolute quantification of nucleic acid sequences as they are amplified. For this reason, fluorescent labels are used to detect specific disease sequences and mutations in cancer genes. Fluorescent labels also vary in photostability and emission maxima, which must be considered when designing experiments.
Modified nucleotides may be added to improve stability and hybridization characteristics of probes. These modifications allow probes to be stored and used under conditions that would normally degrade DNA, such as high temperatures, long incubations with serum samples, and/or long shelf lives. One such stabilization method involves substituting non-bridging oxygen atoms in the phosphate group with sulfur atoms (phosphorothioate backbone). This change allows DNA probes to resist degradation by serum nucleases yet still allow proper Watson-Crick base pairing. Phosphorothioate backbones are useful when probes are required to remain in serum, such as in diagnostic assays, or need long incubation periods. Minor groove binders and non-nucleosidic linker may also be used to stabilize probes by increasing melting temperatures with the ability to titrate. These types of modifications help increase probe stability, prevent degradation by patient samples, and allow for more consistent readings.
Making oligonucleotide reagents suitable for diagnostic applications, instead of merely being suitable for research applications, involves putting into place good practices and controls so that they can be reliably produced at scale with predictable clinical quality. Clinical-grade oligos will adhere to various quality metrics related to their synthesis, purification, analytics, and record keeping. This effort is magnified when developing an oligo for use in a regulated in vitro diagnostic product. Important factors include ensuring process control and comparability across production lots as well as traceability of materials used throughout production. This is important when using these reagents for quantitative assays that require calibration or for diagnostics where false results could have serious implications. These aspects include scaling up production of the oligo such that the synthesis methods used are proven to work at production volumes with the same degree of purity and chemical specification. Quality assurance methods must also be implemented to enable regulatory filings.
Batch-to-batch reproducibility (consistency of batches made on different days and in different quantities) is crucial to diagnostic oligonucleotides. Batch-to-batch reproducibility allows clinicians to compare patient samples over time, or compare samples from different labs. Several factors during oligonucleotide synthesis affect batch-to-batch reproducibility. Incomplete coupling during solid-phase synthesis of oligonucleotides, differences in deprotection conditions, or differences in recovery during purification all affect the actual concentration of active oligonucleotide. Quality assurance steps should be taken at various stages of oligonucleotide synthesis to assess coupling and verify the purity of the intermediate oligonucleotide. Testing of each lot by analytical methods such as chromatography and mass spectrometry assures consistency between batches with respect to identity, purity and performance.
Batch documentation and traceability is another important quality attribute of oligonucleotide reagents. Batch records including specifications and certificates of analysis (CoA) for starting materials, synthesis and purification details, reaction conditions, final testing results and stability studies should be readily available for every batch produced. This allows for any questions related to the performance of a particular lot to be addressed. Unique batch IDs should be traceable from manufacturing of the oligos all the way through kit manufacturing, distribution, and use in patient samples. Traceability allows for quick action should an issue be discovered. Batch record documentation is also helpful for regulatory audits and for any required post-market surveillance.
Custom oligonucleotide synthesis is often required when ordering oligos for diagnostic purposes. Many diagnostic applications require specialized chemistries that are not available from standard catalogs such as unique fluorophore/quencher pairings, backbone modifications to increase stability or unique linker attachments to affinity tags. In addition, production of diagnostic tests requires batch consistency, large quantity production and stringent quality controls that are often only guaranteed through custom synthesis and validated processes. Manufacturing oligonucleotides for diagnostic use also requires facilities that meet certain quality controls and adhere to regulatory compliance for in vitro diagnostic use. If a diagnostic developer is faced with unique sequence needs, modification needs, or requires a consistent source of oligos with defined specifications custom synthesis may be the only solution.
Diagnostic kits and assays often rely on oligonucleotides with unique sequences or modifications not typically stocked by chemical suppliers. Assays such as multiplex probes or molecular beacons often require multiple modifications that need to be in specific locations along the oligo, such as an internal fluorophore, unique quencher or backbone modification that is not commercially available. Diagnostic kits also need to be produced in large quantities from the development phase up through production levels with full quality control in each production lot. Attributes such as well documented synthesis, long term stability, and tracking require custom oligonucleotides with established quality agreements rather than purchasing bulk.
Custom synthesis of oligonucleotides is required for diagnostic applications that involve new chemical functionalities or biomolecule conjugations that are not commercially available. These diagnostic assays may need unique backbone chemistries such as phosphorothioate, LNA, or morpholinos to achieve desired assay performance. Another example would include site-directed conjugation of DNA with proteins, peptides, sugars, or other small molecules for targeted delivery or detection. These modifications require orthogonal protection and purification strategies that are available through custom oligonucleotide synthesis. The ability to create these specialized molecules makes custom synthesis ideal for the development of companion diagnostics.
| Requirement Category | Specific Need | Custom Solution |
| Chemical complexity | Multiple or internal modifications, novel conjugations | Tailored synthesis with specialized amidite chemistry |
| Manufacturing scale | From validation through commercial production | Scalable processes with consistent quality |
| Regulatory compliance | Documentation, traceability, stability data | Quality management system support |
| Performance specifications | Unique binding affinity, specificity, or stability | Sequence optimization and modification design |
Table 3 Indicators for Custom Oligonucleotide Synthesis in Diagnostics
PCR and qPCR performance is directly influenced by primer and probe design, synthesis accuracy, purification level, and batch consistency. In molecular diagnostics, even minor variations in oligonucleotide quality can affect sensitivity, specificity, and reproducibility. Our capabilities in PCR and diagnostic oligonucleotide synthesis include:
Whether for exploratory research, assay development, or commercial diagnostic programs, carefully controlled oligonucleotide synthesis reduces variability and supports reliable amplification performance.
Primer and probe-related issues—such as non-specific amplification, low signal intensity, or inconsistent Ct values—are often linked to design limitations or oligonucleotide quality. If your project involves:
a detailed review of primer and probe specifications can help identify potential optimization opportunities before large-scale implementation. Contact our team to discuss your PCR or diagnostic oligonucleotide requirements and determine the most suitable synthesis and purification strategy for your assay.
References
